Legence (FRA:OO6) Research & Development: €0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OO6 Legence Corp FRA:OO6
18 GF Score
Price €44.80
! 2 Warning Signs
View Full Analysis

What is Legence Research & Development?

Legence FRA:OO6 -0.44% 18 Research & Development is €0 Mil as of Jun. 2026. GuruFocus rates FRA:OO6 with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Legence's Research & Development for the three months ended in Jun. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was €0 Mil.

Legence  (FRA:OO6) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Legence Research & Development Related Terms

Legence Research & Development Historical Data

* Premium members only.

The historical data trend for Legence's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Legence Research & Development Chart

Legence Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00

Legence Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:OO6
18GF Score
Legence Corp FRA:OO6
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Legence Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Legence (FRA:OO6) has a Research & Development of €0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Legence and its competitors.
Is Legence's Research & Development too high?
Legence's current Research & Development is €0 Mil. Overall, Legence has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Legence's Research & Development compare to PRIM and MYRG?
Legence's Research & Development of €0 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Construction company?
A good Research & Development depends on the Construction industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Legence and its competitors. Legence's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Legence stock overvalued right now?
Legence (FRA:OO6) has a current Research & Development of €0 Mil. The current Research & Development is €0 Mil. Legence's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Legence (FRA:OO6), the current Research & Development is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Legence Business Description

Other Exchanges LGN:USA
Address 1601 Las Plumas Avenue, San Jose, CA, USA, 95133
Legence Corp is a provider of engineering, installation, and maintenance services for critical systems in buildings. It focuses on sectors that have technically demanding buildings, including technology, life sciences, healthcare, and education. Legence specializes in designing, fabricating, and installing complex heating, ventilation, and air conditioning (HVAC), process piping, and other mechanical, electrical, and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting, and building controls in existing facilities to enhance building performance, reliability, and efficiency. The services are mainly provided on a fixed price basis. The company has two reportable segments: Installation and Maintenance, which generates the maximum revenue, and Engineering and Consulting.
18GF Score

Get the complete analysis for FRA:OO6

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€44.80
Price